UCL Business / UCLB

Helps UCL Business by converting university IP into startups through proof-of-concept funding, licensing, and equity support.

UCL Business, or UCLB, is the wholly owned commercialisation subsidiary of University College London. It works with UCL and partner hospitals including University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children, and the Royal Free London Hospital to move research into use and return revenue to the university. The organisation is based in the United Kingdom and operates as a translational arm of the university rather than as a standalone venture fund.

Its routes mix grants, equity, and licensing. The Commercial Proof of Concept fund reaches up to £75,000, the Social Ventures POC Fund up to £20,000, UCLB Seed Investments up to £250,000, and the UCL Technology Fund runs separate tracks for proof of concept, therapeutic licensing, and spinout companies up to £5,000,000. The named translational route on this record, UCL Business Translational Funding, is capped at £500,000 and points to work in biotechnology, medical technology, and materials, with UCLB also backing projects across energy, engineering, healthcare, and the environment.

Applicants do not come through open external calls. UCLB uses business managers and a continuous review process, with engagement centered on UCL researchers and UCL-derived IP. That makes it strongest for teams that need translational capital, licensing support, or spinout backing, and less relevant for outsiders looking for a general research grant competition. The record also shows that this is a commercialization office with a long-run role in turning academic ideas into companies and funded development paths.